The scientist’s investigation covers issues in Internal medicine, Alzheimer's disease, Genetics, Immunology and Pathology. Her Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Oncology. The concepts of her Alzheimer's disease study are interwoven with issues in Amyloid beta, Central nervous system disease, Neuroscience, Degenerative disease and Neurodegeneration.
Her work in Genetics covers topics such as Apolipoprotein E which are related to areas like Odds ratio and Polymorphism. As a member of one scientific family, Daniela Galimberti mostly works in the field of Immunology, focusing on Cerebrospinal fluid and, on occasion, Disease and Inflammation. Her study in the field of Frontotemporal lobar degeneration and Frontotemporal dementia is also linked to topics like Stain.
Daniela Galimberti spends much of her time researching Internal medicine, Disease, Frontotemporal dementia, Pathology and Genetics. Her Internal medicine research includes themes of Gastroenterology, Endocrinology and Oncology. Her Disease study combines topics from a wide range of disciplines, such as Multiple sclerosis, Immunology and Bioinformatics.
Her biological study spans a wide range of topics, including Neuroscience, Cohort and Atrophy. Her work is connected to Allele, Gene, Genome-wide association study, Polymorphism and Genetic association, as a part of Genetics. The study incorporates disciplines such as Apolipoprotein E and Single-nucleotide polymorphism, Genotype in addition to Allele.
Daniela Galimberti mostly deals with Frontotemporal dementia, Internal medicine, Disease, Dementia and C9orf72. Her work deals with themes such as Neurodegeneration, Neuroscience, Cohort and Atrophy, which intersect with Frontotemporal dementia. Her Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Oncology.
Her research integrates issues of microRNA and Central nervous system in her study of Disease. Her work carried out in the field of C9orf72 brings together such families of science as Gastroenterology and Cohort study. Genome-wide association study and Genetic association are among the areas of Genetics where the researcher is concentrating her efforts.
Her main research concerns Frontotemporal dementia, Internal medicine, C9orf72, Dementia and Oncology. Her Internal medicine and Biomarker, Cerebrospinal fluid, Disease and Apolipoprotein E investigations all form part of her Internal medicine research activities. Her Disease research integrates issues from Genetics, Downregulation and upregulation and Gene.
Her study in Oncology is interdisciplinary in nature, drawing from both Frontotemporal lobar degeneration and Cohort. In her research, Immunology is intimately related to Genetic heterogeneity, which falls under the overarching field of Age of onset. Daniela Galimberti combines subjects such as Genome-wide association study and Genetic association with her study of Heritability.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer.
Nature (2011)
Genome-wide association study indentifies variants at CLU and CR1 associated with Alzheimer’s disease
J Lambert;S Heath;G Even;D Campion.
Nature Genetics (2009)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi.
PLOS ONE (2014)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis.
Nature Genetics (2013)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez.
Nature Genetics (2017)
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
E Genin;D Hannequin;D Wallon;K Sleegers.
Molecular Psychiatry (2011)
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Jonathan D Rohrer;Jennifer M Nicholas;Jennifer M Nicholas;David M Cash;John van Swieten.
Lancet Neurology (2015)
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson;Ulf Andreasson;Staffan Persson;Hiroyuki Arai.
Alzheimers & Dementia (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Milan
University of Milan
Karolinska University Hospital
University of Florence
University of Brescia
Istituto Neurologico Carlo Besta
Sunnybrook Health Science Centre
University College London
University of Cambridge
University of Geneva
Vrije Universiteit Brussel
Tampere University
Nanjing University of Information Science and Technology
National Taiwan University
Harvard University
Northeastern University
Commonwealth Scientific and Industrial Research Organisation
University of Paris-Saclay
Karlsruhe Institute of Technology
University of Michigan–Ann Arbor
Queen Mary University of London
University of California, San Diego
Columbia University
Fred Hutchinson Cancer Research Center
University of Hong Kong
University of Sydney